Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Total Liabilities
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has total liabilities worth CN¥1.04 Billion CNY (≈ $152.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 002317 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Warby Parker Inc
NYSE:WRBY
|
USA | $360.60 Million |
|
AIMA Technology Group Co Ltd
SHG:603529
|
China | CN¥14.61 Billion |
|
McGrath RentCorp
NASDAQ:MGRC
|
USA | $1.12 Billion |
|
Daetwyl I
SW:DAE
|
Switzerland | CHF695.90 Million |
|
GOLDEN AGRI-RES ADR/100
F:4G3
|
Germany | €4.94 Billion |
|
Shanghai DZH Ltd
SHG:601519
|
China | CN¥415.96 Million |
|
VGP NV
BR:VGP
|
Belgium | €2.54 Billion |
|
American Eagle Outfitters Inc
NYSE:AEO
|
USA | $2.35 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002317 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Zhongsheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.54 Billion ≈ $225.84 Million |
-20.15% |
| 2023-12-31 | CN¥1.93 Billion ≈ $282.84 Million |
-1.33% |
| 2022-12-31 | CN¥1.96 Billion ≈ $286.64 Million |
+43.63% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.57 Million |
+18.64% |
| 2020-12-31 | CN¥1.15 Billion ≈ $168.22 Million |
-16.22% |
| 2019-12-31 | CN¥1.37 Billion ≈ $200.78 Million |
+6.08% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.27 Million |
+14.90% |
| 2017-12-31 | CN¥1.13 Billion ≈ $164.73 Million |
+40.50% |
| 2016-12-31 | CN¥801.23 Million ≈ $117.24 Million |
-34.57% |
| 2015-12-31 | CN¥1.22 Billion ≈ $179.18 Million |
+200.39% |
| 2014-12-31 | CN¥407.63 Million ≈ $59.65 Million |
+71.24% |
| 2013-12-31 | CN¥238.04 Million ≈ $34.83 Million |
+58.25% |
| 2012-12-31 | CN¥150.41 Million ≈ $22.01 Million |
+62.55% |
| 2011-12-31 | CN¥92.54 Million ≈ $13.54 Million |
-3.13% |
| 2010-12-31 | CN¥95.53 Million ≈ $13.98 Million |
-11.92% |
| 2009-12-31 | CN¥108.46 Million ≈ $15.87 Million |
-23.90% |
| 2008-12-31 | CN¥142.53 Million ≈ $20.86 Million |
-14.74% |
| 2007-12-31 | CN¥167.17 Million ≈ $24.46 Million |
+9.32% |
| 2006-12-31 | CN¥152.93 Million ≈ $22.38 Million |
-- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.